COLOMBIA (AndeanWire, 12 de Noviembre de 2013) En el 80% de los casos de psoriasis cursa de forma leve y se manifiesta con una frecuencia ligeramente mayor en mujeres respecto a los hombres La Psoriasis es algo más que una enfermedad de la piel; se trata de un trastorno autoinmune crónico. Se estima que la […]
Continue ReadingInternacional (Marketwired, 22 de Octubre de 2013) GENEWIZ, Inc., proveedor líder global de servicios genómicos, anunció hoy la expansión de sus operaciones europeas con la introducción de GENEWIZ Alemania.
Continue ReadingCOLOMBIA (Marketwired, 22 de Octubre de 2013) GENEWIZ, Inc., proveedor líder global de servicios genómicos, anunció hoy la expansión de sus operaciones europeas con la introducción de GENEWIZ Alemania. Biserka Bacic-Toplek ha sido nombrado director de ventas para dirigir las operaciones comerciales de GENEWIZ Alemania.
Continue ReadingInternacional (Marketwired, 19 de Septiembre de 2013) El panel de discusión está previsto para el viernes 20 de septiembre a las 12:00 en el Waldorf Astoria, NYC
Continue Reading
Internacional (Marketwired, 11 de Septiembre de 2013) El experto en cáncer de próstata, Dr. David B. Samadi, ofrece gratuitamente una segunda opinión de los resultados de la prueba de PSA durante el mes de concientización sobre el cáncer de próstata
Continue ReadingInternacional (Marketwired, 11 de Septiembre de 2013) Covanta Tulsa Renewable Energy recently partnered with the Drug Enforcement Administration (DEA) of Arkansas and Texas to safely destroy over 44,000 pounds of unwanted medications collected during National Prescription Drug Take-Back Day. The collected drugs are combusted at high temperatures and converted into clean, renewable energy at no charge through Covanta's Rx4Safety program.
Continue ReadingInternacional (Marketwired, 10 de Septiembre de 2013) Nuvilex, Inc. (OTCQB: NVLX) (Company), an international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, announced today it has contracted Fisher BioServices, Inc. for the long-term storage of cells that will be required for its future Phase 3 and other cancer clinical trials.
Continue ReadingCOLOMBIA (AndeanWire, 09 de Septiembre de 2013) Pinacle Enterprise, Inc. (OTCBB: PINS) (OTCQB: PINS) is pleased to announce that it has signed a Letter of Intent to acquire Xtreme Technologies, Inc. ("Xtreme Technologies"), developer and holder of the worldwide intellectual property, patents, and rights to the technologies behind the Company's Alkame™ micro-clustered, alkaline, antioxidant, and oxygenated water.
Continue ReadingInternacional (Marketwired, 09 de Septiembre de 2013) Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional supplements company, is pleased to announce they have signed an agreement with a leading Mexican pharmaceutical company, Industria Farmaceutica Andromaco, S.A. de C.V.
Continue ReadingInternacional (Marketwired, 09 de Septiembre de 2013) PFB Corporation (TSX:PFB) ("PFB or the "Corporation") announced today that it will be proceeding with a normal course issuer bid to purchase, through the facilities of the Toronto Stock Exchange (TSX), up to a maximum of 50,000 of its common shares, representing 0.74% of PFB Corporation's issued and outstanding common shares, which, as of the date hereof, is 6,739,203 subject to a daily maximum of 1,000 common shares. The average daily trading volume of the Corporation's shares for the past six months was 1,159 shares. Purchases by Corporation can commence on September 11, 2013 and will end no later than September 10, 2014.
Continue Reading